Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Children With Relapsed Acute Lymphocytic Leukemia
Completed · Phase 2
Conditions studied: Leukemia
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Combining chemotherapy with peripheral stem cell transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more cancer cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating children who have relapsed acute lymphocytic leukemia.
Key facts
- Study ID
- NCT00002638
- Run by
- University of Nebraska
- People needed
- 30
- Starts
- 1995-03-01
- Expected to finish
- 2005-03-01
- Last updated by the study team
- 2013-07-10
Who can join
Age: 1 and older, up to 19. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Nebraska Medical Center — Omaha, Nebraska, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.